聚谷氨酰胺肽的溶解与解聚
Solubilization and disaggregation of polyglutamine peptides.
作者信息
Chen S, Wetzel R
机构信息
Graduate School of Medicine, University of Tennessee Medical Center, Knoxville, Tennessee 37920, USA.
出版信息
Protein Sci. 2001 Apr;10(4):887-91. doi: 10.1110/ps.42301.
Abstract
A method is described for dissolving and disaggregating chemically synthesized polyglutamine peptides. Polyglutamine peptides longer than about Q20 have been reported to be insoluble in water, but dissolution in--and evaporation from--a mixture of trifluoroacetic acid and hexafluoroisopropanol converts polyglutamine peptides up to at least Q44 to a form readily soluble in aqueous buffers. This procedure also has a dramatic effect on peptides which appear to be completely soluble in water, by removing traces of aggregate that seed aggregation. The protocol makes possible solution studies-including in vitro aggregation experiments--on polyglutamine peptides with repeat lengths associated with increased risk of Huntington's Disease and other expanded CAG repeat diseases. It may also be useful in conducting reproducible, quantitative aggregation studies on other polypeptides.
摘要
描述了一种溶解和分解化学合成的聚谷氨酰胺肽的方法。据报道，长度超过约Q20的聚谷氨酰胺肽不溶于水，但在三氟乙酸和六氟异丙醇的混合物中溶解并蒸发后，可将至少长达Q44的聚谷氨酰胺肽转化为易溶于水性缓冲液的形式。该方法还通过去除引发聚集的微量聚集体，对似乎完全可溶于水的肽产生显著影响。该方案使得对与亨廷顿舞蹈症及其他CAG重复序列扩展疾病风险增加相关的重复长度的聚谷氨酰胺肽进行溶液研究（包括体外聚集实验）成为可能。它也可能有助于对其他多肽进行可重复的定量聚集研究。
相似文献
1
Solubilization and disaggregation of polyglutamine peptides.聚谷氨酰胺肽的溶解与解聚
Protein Sci. 2001 Apr;10(4):887-91. doi: 10.1110/ps.42301.
2
Unaided trifluoroacetic acid pretreatment solubilizes polyglutamine peptides and retains their biophysical properties of aggregation.未辅助的三氟乙酸预处理可溶解聚谷氨酰胺肽并保留其聚集的生物物理特性。
Anal Biochem. 2016 Feb 1;494:23-30. doi: 10.1016/j.ab.2015.10.006. Epub 2015 Oct 26.
3
Study of solid-phase synthesis and purification strategies for the preparation of polyglutamine peptides.用于制备聚谷氨酰胺肽的固相合成及纯化策略研究。
Biopolymers. 2007;88(5):754-63. doi: 10.1002/bip.20763.
4
Proteasome degrades soluble expanded polyglutamine completely and efficiently.蛋白酶体能够完全且高效地降解可溶性的多聚谷氨酰胺扩增产物。
Neurobiol Dis. 2004 Jun;16(1):202-11. doi: 10.1016/j.nbd.2003.12.020.
5
A microtiter plate assay for polyglutamine aggregate extension.
Anal Biochem. 2001 Aug 15;295(2):227-36. doi: 10.1006/abio.2001.5217.
6
Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity.多聚谷氨酰胺在体外的聚集行为支持细胞毒性的募集机制。
J Mol Biol. 2001 Aug 3;311(1):173-82. doi: 10.1006/jmbi.2001.4850.
7
Synthesis and disaggregation of asparagine repeat-containing peptides.含天冬酰胺重复序列肽段的合成与解聚
J Pept Sci. 2014 Nov;20(11):860-7. doi: 10.1002/psc.2677. Epub 2014 Jul 17.
8
UV Resonance Raman Structural Characterization of an (In)soluble Polyglutamine Peptide.（不）溶性多谷氨酰胺肽的紫外共振拉曼结构特征。
J Phys Chem B. 2019 Feb 28;123(8):1749-1763. doi: 10.1021/acs.jpcb.8b10783. Epub 2019 Feb 19.
9
Random coil conformation for extended polyglutamine stretches in aqueous soluble monomeric peptides.
J Pept Res. 1997 Jul;50(1):73-5. doi: 10.1111/j.1399-3011.1997.tb00622.x.
10
Inhibition of polyglutamine aggregate cytotoxicity by a structure-based elongation inhibitor.
FASEB J. 2004 May;18(7):923-5. doi: 10.1096/fj.03-1238fje. Epub 2004 Mar 4.
引用本文的文献
1
Intrinsic stiffness and -solvent regime in intrinsically disordered proteins: Implications for liquid-liquid phase separation.内在无序蛋白质的固有刚性和溶剂状态：对液-液相分离的影响。
PNAS Nexus. 2025 Feb 5;4(2):pgaf039. doi: 10.1093/pnasnexus/pgaf039. eCollection 2025 Feb.
2
Nucleation of Huntingtin Aggregation Proceeds via Conformational Conversion of Pre-Formed, Sparsely-Populated Tetramers.亨廷顿聚集物的成核是通过预先形成的、稀疏存在的四聚体的构象转换进行的。
Adv Sci (Weinh). 2024 Jun;11(24):e2309217. doi: 10.1002/advs.202309217. Epub 2024 Mar 12.
3
Structure of puromycin-sensitive aminopeptidase and polyglutamine binding.嘌呤霉素敏感氨肽酶的结构与多聚谷氨酰胺结合。
PLoS One. 2023 Jul 13;18(7):e0287086. doi: 10.1371/journal.pone.0287086. eCollection 2023.
4
Molecular Mechanisms of Inhibition of Protein Amyloid Fibril Formation: Evidence and Perspectives Based on Kinetic Models.抑制蛋白淀粉样纤维形成的分子机制：基于动力学模型的证据和观点。
Int J Mol Sci. 2022 Nov 3;23(21):13428. doi: 10.3390/ijms232113428.
5
Quantitative NMR analysis of the kinetics of prenucleation oligomerization and aggregation of pathogenic huntingtin exon-1 protein.定量 NMR 分析致病性 huntingtin 外显子 1 蛋白的预成核寡聚化和聚集的动力学。
Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2207690119. doi: 10.1073/pnas.2207690119. Epub 2022 Jul 12.
6
Inhibition of Polyglutamine Misfolding with D-Enantiomeric Peptides Identified by Mirror Image Phage Display Selection.通过镜像噬菌体展示选择鉴定的 D-对映体肽抑制多聚谷氨酰胺错误折叠。
Biomolecules. 2022 Jan 18;12(2):157. doi: 10.3390/biom12020157.
7
Template-assisted design of monomeric polyQ models to unravel the unique role of glutamine side chains in disease-related aggregation.用于揭示谷氨酰胺侧链在疾病相关聚集中独特作用的单体多聚谷氨酰胺模型的模板辅助设计。
Chem Sci. 2020 Oct 28;12(1):412-426. doi: 10.1039/d0sc05299j. eCollection 2021 Jan 7.
8
Ultraviolet Resonance Raman Spectroscopic Markers for Protein Structure and Dynamics.用于蛋白质结构与动力学的紫外共振拉曼光谱标记物
Trends Analyt Chem. 2018 Jun;103:223-229. doi: 10.1016/j.trac.2017.12.002. Epub 2017 Dec 11.
9
Polyglutamine Solution-State Structural Propensity Is Repeat Length Dependent.多聚谷氨酰胺溶液构象结构倾向性与重复长度相关。
J Phys Chem B. 2019 May 16;123(19):4193-4203. doi: 10.1021/acs.jpcb.9b01433. Epub 2019 May 1.
10
UV Resonance Raman Structural Characterization of an (In)soluble Polyglutamine Peptide.（不）溶性多谷氨酰胺肽的紫外共振拉曼结构特征。
J Phys Chem B. 2019 Feb 28;123(8):1749-1763. doi: 10.1021/acs.jpcb.8b10783. Epub 2019 Feb 19.
本文引用的文献
1
Fourteen and counting: unraveling trinucleotide repeat diseases.数量已达十四且仍在增加：破解三核苷酸重复疾病之谜。
Hum Mol Genet. 2000 Apr 12;9(6):909-16. doi: 10.1093/hmg/9.6.909.
2
Inhibition of aggregation side reactions during in vitro protein folding.
Methods Enzymol. 1999;309:217-36. doi: 10.1016/s0076-6879(99)09017-5.
3
Methodological and chemical factors affecting amyloid beta peptide amyloidogenicity.影响β淀粉样肽淀粉样变性的方法学和化学因素。
Methods Enzymol. 1999;309:189-204. doi: 10.1016/s0076-6879(99)09015-1.
4
Peptide models for inherited neurodegenerative disorders: conformation and aggregation properties of long polyglutamine peptides with and without interruptions.遗传性神经退行性疾病的肽模型：有或无中断的长聚谷氨酰胺肽的构象和聚集特性
FEBS Lett. 1999 Jul 30;456(1):181-5. doi: 10.1016/s0014-5793(99)00933-3.
5
Molecular basis of the neurodegenerative disorders.神经退行性疾病的分子基础。
N Engl J Med. 1999 Jun 24;340(25):1970-80. doi: 10.1056/NEJM199906243402507.
6
Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology.含多聚谷氨酰胺的亨廷顿蛋白片段自组装成淀粉样原纤维：对亨廷顿舞蹈病病理学的启示
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4604-9. doi: 10.1073/pnas.96.8.4604.
7
Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins.
Annu Rev Biochem. 1997;66:385-407. doi: 10.1146/annurev.biochem.66.1.385.
8
Mad cows meet psi-chotic yeast: the expansion of the prion hypothesis.疯牛病与精神错乱的酵母相遇：朊病毒假说的扩展
Cell. 1997 May 16;89(4):495-8. doi: 10.1016/s0092-8674(00)80231-7.
9
Inclusion bodies and purification of proteins in biologically active forms.包含体与生物活性形式蛋白质的纯化
Adv Biochem Eng Biotechnol. 1997;56:61-109. doi: 10.1007/BFb0103030.
10
Perfluorinated acid alternatives to trifluoroacetic acid for reversed-phase high-performance liquid chromatography.
J Chromatogr A. 1996 Oct 11;746(2):277-81. doi: 10.1016/0021-9673(96)00377-9.
Zotero 插件